✦ LIBER ✦

Combined intensive chemoradiotherapy for organ preservation in patients with resectable and non-resectable oesophageal cancer

✍ Scribed by E. Roca; E. Pennella; M. Sardi; S. Carraro; M. Barugel; C. Milano; A. Fiorini; R. Giglio; G. Gonzalez; R. Kneitschel; E. Aman; A. Jarentchuk; C. Blajman; J. Nadal; M.T. Santarelli; A. Navigante

Book ID: 116166604
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 514 KB
Volume: 32
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)00524-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic Factors for Survival and Rese

Prognostic Factors for Survival and Resection in Patients With Initial Nonresectable Locally Advanced Pancreatic Cancer Treated With Chemoradiotherapy

✍ Jon K. Bjerregaard; Michael B. Mortensen; Helle A. Jensen; Morten Nielsen; Per P 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 659 KB

A phase I/II study of oxaliplatin and pa

A phase I/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische Onkologie

✍ Volker Kaechele; Markus Moehler; Manfred P. Lutz; Goetz von Wichert; Miriam Eise 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 214 KB

Survival Comparisons for Patients Presen

Survival Comparisons for Patients Presenting with Peritoneal Surface Disease and Undergoing Non-Curative Resection of the Primary Tumours in Advanced Colorectal Cancers

✍ Muhammad Imran Aslam; Ashish Kelkar; David Sharpe; John Stuart Jameson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 131 KB

22 Phase II pilot study of neoadjuvant c

22 Phase II pilot study of neoadjuvant cetuximab in combination with cisplatin and gemcitabine in patients with resectable 1B-IIIA non-small-cell lung cancer: preliminary results

✍ Coate, L.; Cuffe, S.; Gately, K.; Barr, M.; Meaney, J.; O'Connell, F.; Nicholson 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Risk factors for local and regional recu

Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy

✍ Lopez Guerra, J. L.; Gomez, D. R.; Lin, S. H.; Levy, L. B.; Zhuang, Y.; Komaki, 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 227 KB

Lung resection for non–small-cell lung c

Lung resection for non–small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population

✍ Özcan Birim; H.Mischa Zuydendorp; Alexander P.W.M Maat; A.Pieter Kappetein; Mari 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 113 KB